Estimates Revisions Niagen Bioscience, Inc. Deutsche Boerse AG
Stocks
OCD1
US1710774076
Biotechnology & Medical Research
|
Market Closed -
Deutsche Boerse AG
02:04:04 2026-09-01 EDT
|
Pre-market 01:30:26 | |||
| 2.440 EUR | -5.43% |
|
2.700 | +10.66% |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- NAGE Stock
- OCD1 Stock
- Consensus Niagen Bioscience, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
